Artivion, Inc. (AORT)
45.61
-0.38
(-0.83%)
USD |
NYSE |
Dec 31, 16:00
45.63
+0.02
(+0.04%)
Pre-Market: 20:00
Artivion Cash from Investing (Quarterly): -4.609M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Edwards Lifesciences Corp. | -661.50M |
| Pulse Biosciences, Inc. | -0.062M |
| INVO Fertility, Inc. | -0.0081M |
| NeuroOne Medical Technologies Corp. | -0.0106M |
| Nutriband, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 20.51M |
| Cash from Financing (Quarterly) | 4.067M |
| Free Cash Flow | 15.75M |
| Free Cash Flow Per Share (Quarterly) | 0.326 |
| Free Cash Flow to Equity (Quarterly) | 17.66M |
| Free Cash Flow to Firm (Quarterly) | 21.54M |
| Free Cash Flow Yield | 0.77% |